Literature DB >> 21565257

Depotentiation of hippocampal long-term potentiation depends on genetic background and is modulated by cocaine self-administration.

M Miguéns1, S M Coria, A Higuera-Matas, A Fole, E Ambrosio, N Del Olmo.   

Abstract

Lewis (LEW) and Fischer 344 (F344) rats differ in their response to drugs and are frequently used as an experimental model to study vulnerability to drug addiction. We have previously reported that significant differences in hippocampal synaptic plasticity exist between LEW and F344 rats after non-contingent chronic cocaine administration. However, given the several biochemical differences between contingent and non-contingent administration of drugs, we have studied here the possible genetic differences in synaptic plasticity after contingent cocaine self-administration. LEW and F344 animals self-administered cocaine (1 mg/kg i.v.) or saline under a fixed ratio 1 schedule of reinforcement for 20 days. After self-administration, electrophysiological experiments were carried out in which hippocampal slices were tetanized with three high frequency pulses in order to induce long-term potentiation (LTP). After a 20 min period of LTP stabilization, a train of low frequency stimulation (LFS; 900 pulses, 1 Hz) was applied to induce depotentiation of LTP. Data showed no differences between cocaine self-administered LEW or F344 rats in the induction of saturated-LTP compared to saline animals. LEW saline self-administered rats showed normal LTP depotentiation whereas cocaine self-administration impaired depotentiation in this rat strain. In the F344 strain, depotentiation of saturated-LTP was impaired both in saline and cocaine self-administered rats. The present results corroborate previous findings showing differences in basal hippocampal synaptic plasticity between LEW and F344 rats. These differences seem to modulate cocaine effects in a manner independent of contingency of drug administration.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21565257     DOI: 10.1016/j.neuroscience.2011.04.056

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  6 in total

1.  Striatal Nurr1, but not FosB expression links a levodopa-induced dyskinesia phenotype to genotype in Fisher 344 vs. Lewis hemiparkinsonian rats.

Authors:  Kathy Steece-Collier; Timothy J Collier; Jack W Lipton; Jennifer A Stancati; Mary E Winn; Allyson Cole-Strauss; Rhyomi Sellnow; Melissa M Conti; Natosha M Mercado; Eduardo A Nillni; Caryl E Sortwell; Fredric P Manfredsson; Christopher Bishop
Journal:  Exp Neurol       Date:  2020-05-05       Impact factor: 5.330

2.  Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.

Authors:  Rhyomi C Sellnow; Kathy Steece-Collier; Feras Altwal; Ivette M Sandoval; Jeffrey H Kordower; Timothy J Collier; Caryl E Sortwell; Anthony R West; Fredric P Manfredsson
Journal:  J Neurosci       Date:  2020-04-01       Impact factor: 6.167

3.  3D Synaptic Organization of the Rat CA1 and Alterations Induced by Cocaine Self-Administration.

Authors:  L Blazquez-Llorca; M Miguéns; M Montero-Crespo; A Selvas; J Gonzalez-Soriano; E Ambrosio; J DeFelipe
Journal:  Cereb Cortex       Date:  2021-03-05       Impact factor: 5.357

Review 4.  Fischer 344 and Lewis Rat Strains as a Model of Genetic Vulnerability to Drug Addiction.

Authors:  Cristina Cadoni
Journal:  Front Neurosci       Date:  2016-02-09       Impact factor: 4.677

5.  Conditioned place preference training prevents hippocampal depotentiation in an orexin-dependent manner.

Authors:  Guan-Ling Lu; Hau-Jie Yau; Lih-Chu Chiou
Journal:  J Biomed Sci       Date:  2017-09-06       Impact factor: 8.410

6.  Neuroimaging reveals distinct brain glucose metabolism patterns associated with morphine consumption in Lewis and Fischer 344 rat strains.

Authors:  Mª Luisa Soto-Montenegro; Verónica García-Vázquez; Nicolás Lamanna-Rama; Gonzalo López-Montoya; Manuel Desco; Emilio Ambrosio
Journal:  Sci Rep       Date:  2022-03-17       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.